Dr. Dong Shin, MD

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Yonsei University / College Of Medicine

  Medical School, 1975

• Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact, 2010-08-16

• Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy, 2015-07-30

• Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non-Small-Cell Lung Cancer, 2013-09-25

• Multiple biological functions of Twist1 in various cancers, 2017-01-12

• Systemic Delivery of siRNA-Nanoparticles Targeting RRM2 Suppresses Head and Neck Tumor Growth, 2012-02-08

• Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population--A SEER-based analysis from 2000 to 2016, 2021-07-20

• Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer, 2021-02-13

• Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303, 2014-08-08

• Heregulin and HER3 are Prognostic Biomarkers in Oropharyngeal Squamous Cell Carcinoma, 2015-07-20

• Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma, 2022-06-01

• A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer, 2022-05-26

• Phase IB study of induction chemotherapy with XELOX, followed by radiation therapy, Carboplatin and Everolimus in patients with locally advanced Esophageal Cancer., 2019-01-21

• HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers, 2017-12-28

• Role of COX-2 in tumor progression and survival of head and neck squamous cell carcinoma, 2009-09-08

• Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy, 2017-01-11

• Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth, 2017-11-15

• Evasion of anti-growth signaling: a key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds, 2015-03-06

• Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial, 2023-04-03

• Farnesyl Transferase Expression Determines Clinical Response to the Docetaxel-Lonafarnib Combination in Patients with Advanced Malignancies, 2011-03-01

• Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts, 2012-04-25

• Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study, 2013-10-03

• Signatures of somatic mutations and gene expression from p16INK4Apositive head and neck squamous cell carcinomas (HNSCC), 2020-09-28

• Phase 1B Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck, 2020-09-17

• Phase I and pharmacokinetic study of everolimus, an mTOR inhibitor, in combination with docetaxel for recurrent/refractory non-small cell lung cancer, 2010-08-15

• Human Papillomavirus Oncoprotein E6 Upregulates c-Met through p53 Downregulation, 2016-07-22

• Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers, 2020-09-06

• A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model, 2011-07-11

• Small Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy, 2015-05-21

• Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy, 2015-10-30

• Targeted Delivery of Paclitaxel to Tumor Cells: Synthesis andIn VitroEvaluation, 2010-04-22

• Soy isoflavone supplementation increases long interspersed nucleotide element-1 (LINE-1) methylation in head and neck squamous cell carcinoma, 2019-03-12

• A Broad-Spectrum Integrative Design for Cancer Prevention and Therapy, 2016-03-12

• Modulation of Bax and mTOR for cancer therapeutics, 2017-04-05

• RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy, 2013-05-29

• Plasma metabolic phenotypes of HPV-associated vs smoking-associated head and neck cancer and patient survival, 2021-08-10

• A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy, 2022-08-15

• Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas, 2022-01-28

• Associations among HPV, inflammation, and fatigue in head and neck cancer patients, 2018-05-09

• HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors, 2009-10-27

• Long-term use of valproic acid in United States Veterans associates with reduced risk of smoking related head-and neck cancer, 2014-03-24

• A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands, 2010-10-26

• Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma, 2017-09-25

• The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms, 2020-10-20

• High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV, 2016-11-29

• Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma (HNSCC), 2014-04-18

• Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer, 2018-09-11